Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
CSR Index
To those who requested this Index: Response was so great that
Barbara and John have suggested it just be posted to the entire
Parkinsn. list as updated (monthly). We'll see how it goes this
way. Cheers,
Joe
I N D E X , C U R R E N T S C I E N C E R E V I E W S
(Revised July 1996)
SUBJECT CSR SOURCE JOURNAL JOURNAL REF.
DATE
Absorption, levodopa Jun 96 Neur 1996;46:1051-1054
Acetazolamide (Diamox) Nov 95 Movement Disorders 1993;8:240-241
" Jun 96 Neur 1995;458-460
Agonists, action May 95 Neur 1995;45S3:S5
Albuterol Dec 94 Neur 1994;8:1511-1513
Alzheimer's and PD Apr 95 Ann Neur 1995;37:300-312
Amantadine (Symmetrel) Jul 96 Neur 1996;46:1551-1556
Apomorphine, PD effcts Dec 94 J Neur N'surg Psych 1994;8:998-1001
" , availability Apr 95 Lancet 1995;345:517-518
", self-injection Jul 95 J Neur N'surg Psych 1995;58:681-687
Apoptosis Feb 96 Ann Neur 1995;38:839-851
Botulinum toxin Jun 96 Neur 1995;45:822-824
Boxers, parkinsonism Jul 95 J Neur N'surg Psych 1995;58:688-691
Bromocryptine Dec 94 J Neur N'surg Psych 1994;8:903-910
" Mar 96 Lancet 20 Jan 1996:196
Cabergoline Jan 95 Arch Neur 1994;51:1236-1241
" Dec 95 Lancet 11 Nov 1995:1290
" Jun 96 Neur 1996;46:1062-1065
Cerebellum, in ET Jun 96 Neur 1996;46:1200-1205
" " Jun 96 Ann Neur 1996;39:650-658
Clozapine (Clozaril) Apr 95 Lancet 1995;345:517-518
" Apr 95 Neur 1995;45:432-434
Cognitive decline Feb 95 J Neur N'surg Psych 1995;58:51-55
" Jun 96 J Neur N'surg Psych 1996;60:564-571
Color discrimination Mar 95 Neur 1995;45:386-387
" Jul 95 Brain 1995;118:771-778
Constipation Nov 95 Lancet 1995;346:861-864
DATATOP Nov 95 Arch Neur 1995;52:565-570
" Mar 96 Ann Neur 1996;39:29-36
Dementia, PD vs AD Jul 95 Neur 1995;45:1025
" , preclinical Jan 96 Neur 1995;45:1691-1696
" , incidence Jun 96 Neur 1995;45:705-708
" , " Jul 96 Arch Neur 1996;53:538-542
Depression Mar 96 Arch Neur 1996;53:175-179
DLBD Jun 96 J Neur N'surg Psych 1996;60:531-538
Dopamine transporter Mar 96 Science 16 Feb 1996:909
Down's syndrome Feb 95 Neur 1994;44:2419
Driving ability Feb 96 JAMA 17 Jan 1996:182
Dyskinesia Jul 96 Neur 1996;46:1548-1551
Eldepryl (selegiline) Dec 94 Ann Neur 1994;36;759-764
Electroconvulsive (PSP)Jun 96 Neur 1996;46:1284-1286
Encephalitis, childhoodJun 96 J Neur N'surg Psych 1996;60:589
Entacapone Feb 96 J Neur N'surg Psych 1996;60:36-40
Enteric nervous system Jun 96 NEJM 25 Apr 96:1106-1115
Essential tremor, VIM Jun 96 Neur 1996;46:1150-1153
" , and PD Jun 96 Neur 1995;45:645-648
" , botulinum Jun 96 Neur 1995;45:822-824
" , migraine Jun 96 Neur 1996;46:458-460
" , etiology Jun 96 Neur 1996;46:1200-1205
" , PET scan Jun 96 Ann Neur 1996;39:650-658
Ethanol and ET Jun 96 Ann Neur 1996;39:650-658
Etiology of PD Jun 96 Neur 1996;46:1044-1050
" Jun 96 Neur 1996;46:1270-1274
" Jun 96 Neur 1996;46:1275-1284
Expression Jan 96 Neur 1995;45:1696-1702
Eye movement Jan 95 Neur 1994;44:2285
Fetal transplant Oct 95 Ann Neur 1995;38:379-388
" Apr 96 Brain 1996;119:41-50
" (pig) Nov 95 Science News 7 Oct 1995:230
Free radicals Jun 96 Science News 18 May 1996:311
Gait, improvement Jul 96 Brain 1996;119:551-558
Gamma knife Jun 96 Ann Neur 1996;39:535-538
Ganglioside GM1 Sep 95 Neur 1995;45:1149-1154
Gene, mutation Jun 95 Lancet 1995;345:958
" Jan 96 Neur 1995;45:1760-1763
Gene transfer Aug 95 Science News 29 Jul 1995:73
" May 96 Science 12 Apr 1996;263
Glucose tolerance Jan 96 Int J Neur 1994;69:125-130
Glutamate antagonist Jun 96 Ann Neur 1996;39:574-578
" Jun 96 Ann Neur 1996;39:557-558
Guillain-Barre Sep 95 Ann Neur 1995;38:218-224
Hallucinations Jun 96 Neur 1995;45:659-671
Heredity Apr 95 Neur 1995;45:502-506
" Oct 95 Ann Neur 1995;38:373-378
" Feb 96 Science News 6 Jan 96:4
" Jun 96 Neur 1996;46:1275-1284
Histaminergic neurons Jul 96 Neur 1996;46:1693-1696
Inderal, for dyskinesiaJul 96 Neur 1996;46:1548-1551
Iron, possible cause Jul 96 Lancet 8 Jun 1996;1614
Iron, elevated Jan 95 Ann Neur 1994;36;876-881
" Oct 95 Neur 1995;45:1138-1143
Kava Jun 95 J Neur N'surg Psych 1995;58:639-640
Keats, John Jan 95 Arch Neur 1994;51:1182-1183
Leukemia drugs Jul 95 Ann Neur 1995;37:810-814
Levodopa strategy Oct 95 Ann Neur 1995;38:389-395
" Dec 95 J Neur N'surg Psych 1995;59:555
Levodopa effects Jan 96 Neur 1995;45:1757-1760
" Jun 96 Neur 1996;46:1430-1436
Levodopa ethylester Apr 96 Ann Neur 1996;39:400-404
Lewy body disease Jun 96 J Neur N'surg Psych 1996;60:531-538
Locus coeruleus Jun 95 Brain 1995;118:131-143
Machado-Joseph Nov 95 Ann Neur 1995;38:684-687
Magnetic stimulation May 96 Brain 1996;119:71-77
MAO-B Jun 96 Neur 1996;46:1262-1269
Melatonin Jun 96 BMJ 18 May 1996;1242-1243
Menstrual effects Jul 95 Neur 1995;45:1028
" Nov 95 Movement Disorders 1993;8:240-241
Metaclopramide (Reglan)Jan 96 JAMA 1995;274:1780-1782
Metronome Jun 96 Lancet 11 May 1996:1337
Mimics of PD Oct 95 Arch Neur 1995;58:294-298
" Oct 95 Brain 1995;118:951-958
" Apr 96 BMJ 16 Mar 1996:724
Mitochondria Sep 95 Science News 5 Aug 1995;84
" Feb 96 Neur 1995;45:2097-2099
Mortality Apr 95 J Neur N'surg Psych 1995;58:293-299
Movement, head and eye Jul 96 Ann Neur 1996;39:749-760
MPTP Dec 94 Ann Neur 1994;36:765-770
Multiple System AtrophyMar 95 Ann Neur 1995;37:204-210
" Sep 95 J Neur N'surg Psych 1995;59:144-151
Nerve Growth Factor Apr 96 J Neurosurg 1996;84:685-689
Neuroleptics (risk) Mar 96 J Neur N'surg Psych 1996;60:213-216
Neurosciences Inst. Dec 95 Science 27 Oct 1995:572
Neurotrophic (GDNF) Apr 96 WSJ 21 Mar 1996:
Ondansetron (Zofran) Oct 95 Neur 1995;45:1305-1308
On-off effect Dec 95 J Neur N'surg Psych 1995;59:555
Oxidative stress May 95 Neur 1995;45S3:55
" Aug 95 J Neur N'surg Psych 1995;59:90-91
" Apr 96 Ann Neur 1996;39:378-381
Pallidopyramidal Feb 96 Ann Neur 1995;38:954-956
Pallidotomy, boom in Mar 95 WSJ 22 Feb 95:1
" , PET scan Jul 95 Ann Neur 1995;37:776-783
" , benefits Jun 96 Neur 1995;45:753-761
" , gamma knife Jun 96 Ann Neur 1996;39:535-538
" , PET scan Jun 96 Ann Neur 1996;39:450-459
" , technique Jul 96 J Neurosurg 1996;84:194-202
" , benefits Jul 96 Lancet 25 May 96;1490
" , benefits Jul 96 Ann Neur 1996;39:826
Paroxetine (Paxil) Jan 95 Neur 1994;44:2406
Pathways, neural May 95 Neur 1995;45S3:S28-S34
Perception, visual May 96 Brain 1996;119:79-87
Pergolide (Permax) May 95 Neur 1995;45S3:S5
" May 95 Neur 1995;45S3:S13-S21
" May 95 Neur 1995;45S3:S22-S27
PET diagnosis Dec 94 Ann Neur 1994;36:759-764
" Dec 94 Ann Neur 1994;2:176-182
" Jan 96 J Neur N'surg Psych 1995;59:597-600
" Feb 96 Neur 1995;45:1995-2004
" Jun 96 Ann Neur 1996;39:450-459
" Jun 96 Neur 1996;46:1430-1436
" Jun 96 Neur 1996;46:1200-1205
" Jun 96 Ann Neur 1996;39:650-658
" Jul 96 Brain 1996;119:585-591
Pramipexole Apr 96 PDF Newsletter Spr 1996:1
Prions May 96 Science News 13 Apr 1996;228
Progenitor cells Nov 95 Eng. & Sci Sept 95:26
Progression (case hist)Feb 96 NEJM 1996;334:116-118
" Apr 96 JAMA 6 Mar 1996:716
Progressive supran. Jun 96 J Neur N'surg Psych 1996;60:589
Propranolol Jul 96 Neur 1996;46:1548-1551
Prozac (fluoxetine) Nov 95 Neur 1995;45:1855-1858
Psychogenic PD Sep 95 Arch Neur 1995;52:802-810
Reaction time Dec 95 J Neur N'surg Psych 1995;59:499-506
Regeneration, brain Apr 96 Lancet 16 Mar 1996:751
Registry (surveys) Feb 96 Neur 1995;45:1991-1995
" Feb 96 NEJM 1996;334:71-76
" Feb 96 Neur 1995;45:2143-2146
" Feb 96 Arch Neur 1996;53:66-71
Research priorities Nov 95 JAMA 25 Oct 1995:1257-8
Response time, levodopaJun 96 Neur 1996;46:1055-1058
" Jun 96 Neur 1996;46:1059-1062
Restless leg syndrome Feb 96 JAMA 17 Jan 1996:
Selegiline , PET scan Dec 94 Ann Neur 1994;36:759-764
" , benefits Feb 95 Ann Neur 1995;37:95-98
" , DATATOP Apr 95 Arch Neur 1995;52:237-245
" , amphetamine Oct 95 Lancet 1995;346:64
" , DATATOP Nov 95 Arch Neur 1995;52:564-570
" , protection by Jan 96 Ann Neur 1995;38:771-777
" , risks of Jan 96 BMJ 16 Dec 1995:1602-7
" , DATATOP Mar 96 Ann Neur 1996;39:37-45
" , DATATOP Mar 96 Ann Neur 1996;39:29-36
" , in favor of Apr 96 PDF Newsletter Spr 1996:2
" , pro and con Apr 96 BMJ 16 Mar 1996:702-705
Shy-Drager Mar 95 Ann Neur 1995;37:204-210
Sinemet CR Jul 95 J Neur N'surg Psych 1995;58:ad
" Dec 95 Lancet 11 Nov 1995;1290
Smoking and PD Sep 95 Neur 1995;45:1041
" Oct 95 Neur 1995;58:294-298
" Apr 96 Time 11 Mar 1996:60
" Apr 96 Lancet 24 Feb 1996:527
" Apr 96 Ann Neur 1996;39:378-381
" Jun 96 Neur 1996;46:1275-1284
SPECT, diagnosis by Apr 96 Neur 1996;46:278-285
" Apr 96 Neur 1996;46:231-237
Stereotactic Aug 95 J Neurosurg 1995;83:197-205
" Apr 96 Science News 30 Mar 1996:204
Stimulation, chronic Jun 96 Neur 1996;46:1150-1153
Strength, arm Mar 96 Ann Neur 1996;39:79-88
Sweats, control of Mar 95 Ann Neur 1995;37:120-122
Symmetrel (Amantadine) Jul 96 Neur 1996;46:1551-1556
Thalamotomy Jun 96 J Neur N'surg Pych 1996;60:564-571
Thalamus, and tremor Mar 96 Neur 1996;46:75-79
" Jun 96 Neur 1996;46:1150-1153
Therapy, general Jul 96 Western N Med 1994;161:303-308
Time, judgement Mar 96 Science News 17 Feb 1996:101
" May 96 Brain 1996;119:51-70
Toxins, Environmental Dec 94 Ann Neur 1994;36:765-770
" Apr 95 Neur 1995;45:435-439
" Feb 96 Neur 1995'45:2112
Tracking, visual Jun 95 Brain 1995;118:485-493
Tremor, resting PD Jun 96 Neur 1996;46:1359-1370
Ubiquitin Feb 96 Brain 1995;118:1447-1449
Visual perception May 96 Brain 1996;119:79-87
Vision abnormality Oct 95 Neur 1995;45:1144-1148
Visuospatial attention Jun 95 Brain 1995;118:153-166
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks CA 91403
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance